Guardant Health (GH) Receivables (2017 - 2026)

Guardant Health (GH) has 10 years of Receivables data on file, last reported at $143.6 million in Q1 2026.

• Quarterly Receivables rose 20.04% year-over-year to $143.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.6 million (up 20.04% YoY) and the FY2025 annual result came in at $143.0 million, up 25.86% from the prior year.
• Receivables held at $143.6 million in Q1 2026 per GH's latest filing, from $143.0 million in the prior quarter.
• The five-year high for Receivables was $143.6 million in Q1 2026, with the low at $87.4 million in Q1 2022.
• Average Receivables over 5 years is $106.7 million, with a median of $100.2 million recorded in 2022.
• Year-over-year, Receivables dropped 9.29% in 2023 and jumped 34.62% in 2025.
• Guardant Health's Receivables stood at $102.7 million in 2022, then dropped by 8.74% to $93.7 million in 2023, then climbed by 21.32% to $113.7 million in 2024, then grew by 25.86% to $143.0 million in 2025, then climbed by 0.39% to $143.6 million in 2026.
• Business Quant data shows GH's Receivables at $143.6 million in Q1 2026, $143.0 million in Q4 2025, and $120.7 million in Q3 2025.